Average Co-Inventor Count = 4.43
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Infinity Pharmaceuticals, Inc. (37 from 108 patents)
2. Ikena Oncology, Inc. (5 from 15 patents)
3. Keros Therapeutics, Inc. (1 from 15 patents)
4. Kyn Therapeutics (1 from 1 patent)
44 patents:
1. 12152032 - Heterocyclic compounds and uses thereof
2. 12077542 - Indole AHR inhibitors and uses thereof
3. 12071438 - Crystal forms of an ALK2 inhibitor
4. 11555026 - AHR inhibitors and uses thereof
5. 11541059 - Heterocyclic compounds and uses thereof
6. 11358969 - Indole AHR inhibitors and uses thereof
7. 10941162 - Heterocyclic compounds and uses thereof
8. 10919914 - Heterocyclic compounds and uses thereof
9. 10759806 - Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
10. 10696650 - AHR inhibitors and uses thereof
11. 10689388 - Indole AHR inhibitors and uses thereof
12. 10570138 - Indole AHR inhibitors and uses thereof
13. 10329299 - Heterocyclic compounds and uses thereof
14. 10253047 - Heterocyclic compounds and uses thereof
15. 9828377 - Heterocyclic compounds and uses thereof